Alanine-to-threonine substitutions and amyloid diseases: Butyrylcholinesterase as a case study
- 1 September 2010
- journal article
- review article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 187 (1-3), 64-71
- https://doi.org/10.1016/j.cbi.2010.01.003
Abstract
No abstract availableKeywords
Funding Information
- Israel Science Foundation (1876/08)
- The Interdisciplinary Center for Neural Computation at The Hebrew University of Jerusalem
This publication has 60 references indexed in Scilit:
- The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology♦Journal of Biological Chemistry, 2009
- Quantification of the Thermodynamically Linked Quaternary and Tertiary Structural Stabilities of Transthyretin and Its Disease-Associated Variants: The Relationship between Stability and AmyloidosisBiochemistry, 2008
- Altered Dimer Interface Decreases Stability in an Amyloidogenic ProteinJournal of Biological Chemistry, 2008
- Butyrylcholinesterase attenuates amyloid fibril formation in vitroProceedings of the National Academy of Sciences, 2006
- Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation11Edited by F. CohenJournal of Molecular Biology, 2001
- Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patientsNeuroscience Letters, 1998
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradationCell, 1995
- Regional synaptic pathology in Alzheimer's diseaseNeurobiology of Aging, 1992
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980